comparemela.com

Latest Breaking News On - Zentalis pharmaceuticals company profile - Page 5 : comparemela.com

Analysts Set Zentalis Pharmaceuticals, Inc (NASDAQ:ZNTL) PT at $47 10

Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) have earned an average recommendation of “Buy” from the seven analysts that are currently covering the stock, MarketBeat reports. Seven investment analysts have rated the stock with a buy recommendation. The average 1-year price target among brokers that have issued ratings on the stock in […]

Zentalis Pharmaceuticals, Inc (NASDAQ:ZNTL) Receives Consensus Recommendation of Buy from Analysts

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) has received an average recommendation of “Buy” from the six research firms that are covering the firm, MarketBeat reports. Six research analysts have rated the stock with a buy rating. The average 1-year target price among analysts that have issued ratings on the stock in the last […]

Zentalis Pharmaceuticals, Inc (NASDAQ:ZNTL) Given Consensus Recommendation of Buy by Brokerages

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Rating) has been given a consensus recommendation of “Buy” by the twelve research firms that are covering the stock, MarketBeat.com reports. Seven investment analysts have rated the stock with a buy recommendation. The average 12-month price objective among analysts that have issued a report on the stock in the […]

Opaleye Management Inc Buys New Shares in Zentalis Pharmaceuticals, Inc (NASDAQ:ZNTL)

Opaleye Management Inc. bought a new stake in shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Rating) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 167,500 shares of the company’s stock, valued at approximately $3,373,000. Zentalis Pharmaceuticals comprises about 1.2% of […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.